financetom
Business
financetom
/
Business
/
Transocean Pockets $232M Drillship Contract For Deepwater Atlas: Details
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Transocean Pockets $232M Drillship Contract For Deepwater Atlas: Details
Sep 11, 2024 4:47 AM

Transocean Ltd ( RIG ) shares are trading higher premarket Wednesday. On Tuesday, the company disclosed a 365-day contract for the Deepwater Atlas with BP p.l.c ( BP ). in the U.S. Gulf of Mexico.

The program is set to begin in the second quarter of 2028. The contract, including a 365-day option, is expected to add around $232 million to the backlog, excluding mobilization fees, with no additional services provided.

Last week, the company announced that a subsidiary has agreed to sell the Development Driller III and associated assets for $195 million and the Discoverer Inspiration and related assets for $147 million.

The company stated that the total sale amount of $342 million will result in a non-cash charge of $630 million—$645 million in the third quarter due to asset impairment.

In July, the company reported an adjusted EPS of $(0.15), missing the estimate of $(0.10), and sales of $861 million, falling short of the $862.6 million estimate.

As of July 2024, Transocean’s backlog stood at $8.64 billion.

Investors can gain exposure to the stock via Exchange Traded Concepts Trust Range Global Offshore Oil Services Index ETF and SPDR Series Trust SPDR S&P Oil & Gas Equipment & Services ETF .

Price Action: RIG shares are up 4.59% at $4.10 premarket at the last check Wednesday.

Read Next:

Harris Predicts Trump’s Behavior In Upcoming Debate: ‘I Think He’s Going To Lie’

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Monogram Technologies Says US FDA Grants 510(k) Clearance for Monogram mBos TKA System
Monogram Technologies Says US FDA Grants 510(k) Clearance for Monogram mBos TKA System
Mar 17, 2025
08:16 AM EDT, 03/17/2025 (MT Newswires) -- Monogram Technologies ( MGRM ) said Monday that its robotic-assisted total knee arthroplasty system, the Monogram mBos TKA System, has received a 510(k) clearance from the US Food and Drug Administration. Monogram Technologies ( MGRM ) said the approval allows to market the device, subject to the requirements of the Federal Food, Drug,...
Market Chatter: Amazon to Add Premium Tier of Alexa Devices
Market Chatter: Amazon to Add Premium Tier of Alexa Devices
Mar 17, 2025
08:25 AM EDT, 03/17/2025 (MT Newswires) -- Amazon.com ( AMZN ) plans to expand its Alexa device line with a premium tier in a bid to offer consumers more choices, Bloomberg reported Monday, citing the company's head for devices and services Panos Panay. Panay told the news outlet that the voice assistant's new artificial intelligence operating system, Alexa+, will be...
Stellantis invests $41 million in Italy to make EV engine parts
Stellantis invests $41 million in Italy to make EV engine parts
Mar 17, 2025
MILAN (Reuters) - Automaker Stellantis is investing 38 million euros ($41 million) in its Verrone plant in Northern Italy to manufacture parts for electric engines for its upcoming small-size models, it said on Monday. The plant will manufacture steel components for electric drive modules Stellantis ( STLA ) currently makes in other European facilities, the company said in a statement,...
Precision Says its Investigational New Drug Application for Hepatitis B Treatment Gets US FDA's Clearance
Precision Says its Investigational New Drug Application for Hepatitis B Treatment Gets US FDA's Clearance
Mar 17, 2025
08:22 AM EDT, 03/17/2025 (MT Newswires) -- Precision BioSciences ( DTIL ) said Monday its investigational new drug application for PBGENE-HBV in vivo gene editing program has received the US Food and Drug Administration's clearance to treat chronic hepatitis B. The company is in final stages of US site activation to start enrolling participants in its Eliminate-B study in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved